Home > Resources > Company Profiles > Schering-Plough Corporation

Schering-Plough Corporation (SGP)

Email Confirmation

Fred Hassan , CEO/Chairman of the Board/Director

www.schering-plough.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, animal health, and consumer.

Portfolio Articles

The S.E.C. Inspector Calls
Securities regulator asks 300 companies to explain how they set executive pay.
Aug 31 2007
Good News for Pharma Stocks
The sector soars after three companies blow away expectations, and Amgen reports positive research news on its biggest seller.

Apr 19 2007

See more news on this company

News Feeds

Final Glance: Pharmaceuticals companies AP
Sep 05 2008
Midday Glance: Pharmaceuticals companies AP
Sep 05 2008
Early Glance: Pharmaceuticals companies AP
Sep 05 2008
House committee widens probe of Vytorin safety AP
Sep 04 2008
Ahead of the Bell: Vertex downgraded AP
Sep 03 2008
Docs' caution hurts Merck, Schering-Plough shares AP
Sep 02 2008
Schering-Plough spent $530,000 lobbying in 2Q AP
Aug 29 2008
Schering-Plough: EU OKs product sale to Pfizer AP
Aug 27 2008
Fitch lifts rating watch on Schering-Plough AP
Aug 14 2008
Olympic athletes endorse skin care products AP
Aug 14 2008

Press Releases

Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 Aug-19-2008, 07:30AM EDT
U.S. Hospital Sales Opportunities Maximized Through Functional Optimization Aug-15-2008, 03:07PM EDT
Fitch Affirms & Removes Schering-Plough's 'BBB+' IDR From Watch Negative Aug-14-2008, 03:08PM EDT
Launches of Humira, Golimumab and Orencia for Treatment of Ulcerative Colitis Will Drive Annual Five Percent Market Growth Aug-13-2008, 08:00AM EDT
Schering-Plough Expands Its Presence in China, Enters Next Stage of Development Aug-12-2008, 08:30AM EDT

News From Around the Web

News

College Scholarship Helps Students with Asthma (Standard Journal)

Sep 06 2008
(more…) (Wall Street Journal Health Blog)

Sep 06 2008
Final Glance: Pharmaceuticals companies (Boston Globe)

Sep 05 2008
Early Glance: Pharmaceuticals companies (Boston Globe)

Sep 05 2008
Reps. Dingell, Stupak Write Schering-Plough and Merck on Vytorin-Cancer Link (Drugs.com)

Sep 05 2008
Probe widens on Vytorin safety (CNN)

Sep 05 2008

Blogs

Direct To Consumer Ads: Wasted Money? (In the Pipeline)

Sep 03 2008
Releasing Vytorin Data Is A No-Win Proposition (Pharmalot)

Sep 03 2008
Cramer boots Schering Plough stock (PharmaGossip)

Sep 03 2008
Media Makes Schering-Plough Stock ‘Radioactive’ (Pharmalot)

Sep 03 2008
Was The FDA Given A Secret Vytorin Report? (Pharmalot)

Sep 02 2008

Employees

Number of Employees: 55,000

Revenue per Employee: $346,716

Top Executives

Karl Salnoske, Chief Information Officer/Vice President

C. Ron Cheeley, Divisional Senior VP

Susan Ellen Wolf, Divisional Vice President/Secretary/Other Corporate Officer

Steven H. Koehler, Vice President/Controller

Thomas J. Sabatino, Jr., Executive VP/General Counsel

Robert J. Bertolini, Executive VP/CFO

Lori Queisser, Senior VP, Divisional

John M. Carroll, Vice President, Divisional

Brent Saunders, Divisional President/Senior VP

Joseph J. LaRosa, Divisional Vice President

Raul E. Kohan, Senior VP, Divisional

E. Kevin Moore, Vice President/Treasurer

William J. Creelman, Divisional Vice President

Dr. Thomas P. Koestler, Ph.D., Executive VP/President, Divisional

Dr. Ian A.T. McInnes, President, Divisional/Senior VP

Carrie S. Cox, Divisional President/Executive VP

Board of Directors

Dr. Craig B. Thompson, M.D., Director

Kathryn C. Turner, Director

Thomas J. Colligan, Director

Susan Ellen Wolf, Divisional Vice President/Secretary/Other Corporate Officer

Arthur F. Weinbach, Director

C. Robert Kidder, Director

E. Kevin Moore, Vice President/Treasurer

Carl E. Mundy, Jr., Director

Jack L. Stahl, Director

Eugene R. McGrath, Director

Robert F. W. van Oordt, Director

Patricia F. Russo, Director

Hans W. Becherer, Director

Antonio M. Perez, Director

Financials

Quarterly

Annual

Income Statement	07/2008	04/2008	02/2008	10/2007
Sales	1.91 Bil.	2.14 Bil.	NA	798 Mil.
Gross Operating Profit	3.01 Bil.	2.52 Bil.	3.72 Bil.	2.01 Bil.
Operating Income before D & A (EBITDA)	237 Mil.	-36 Mil.	3.72 Bil.	83 Mil.
Total Income Before Interest Expenses (EBIT)	502 Mil.	599 Mil.	3.72 Bil.	877 Mil.
Total Net Income	436 Mil.	291 Mil.	480 Mil.	750 Mil.
Basic EPS, Total	0.24	0.15	0.27	0.46
Diluted EPS, Total	0.24	0.15	0.27	0.45

BALANCE STATEMENT	07/2008	04/2008	02/2008	10/2007
Cash and Equivalents	NA	NA	NA	12.37 Bil.
Total Assets	NA	NA	NA	17.8 Bil.
Total Liabilities	NA	NA	NA	3.87 Bil.
Total Capitalization	NA	NA	NA	17.96 Bil.

Cash Flow	07/2008	04/2008	02/2008	10/2007
Net Cash From Continuing Operations	NA	NA	NA	1.25 Bil.
Net Cash From Investing Activities	NA	NA	NA	2.64 Bil.
Net Cash From Financing Activities	NA	NA	NA	5.79 Bil.
Net Change in Cash & Cash Equivalents	NA	NA	NA	9.7 Bil.

Income Statement	2008	2007	2006	2005
Sales	4.08 Bil.	3.13 Bil.	2.86 Bil.	2.62 Bil.
Gross Operating Profit	8.61 Bil.	7.46 Bil.	6.65 Bil.	5.66 Bil.
Operating Income before D & A (EBITDA)	414 Mil.	559 Mil.	409 Mil.	237 Mil.
Total Income Before Interest Expenses (EBIT)	2.32 Bil.	1.66 Bil.	497 Mil.	-168 Mil.
Total Net Income	2.26 Bil.	1.1 Bil.	269 Mil.	-947 Mil.
Basic EPS, Total	1.37	0.71	0.12	-0.67
Diluted EPS, Total	1.37	0.71	0.12	-0.67

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	NA	2.67 Bil.	4.77 Bil.	4.98 Bil.
Total Assets	NA	10.42 Bil.	9.73 Bil.	10 Bil.
Total Liabilities	NA	4.16 Bil.	4.66 Bil.	5.21 Bil.
Total Capitalization	NA	10.3 Bil.	9.79 Bil.	9.95 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	2.16 Bil.	882 Mil.	-154 Mil.
Net Cash From Investing Activities	NA	-2.91 Bil.	-454 Mil.	-621 Mil.
Net Cash From Financing Activities	NA	-1.36 Bil.	-633 Mil.	1.53 Bil.
Net Change in Cash & Cash Equivalents	NA	-2.1 Bil.	-217 Mil.	766 Mil.

Schering-Plough Corporation (SGP)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request